Mechanisms of developmental neurotoxicology: theme, rationale and overview
Verity, M.A.
Neurotoxicology 15(1): 5-8
1994
ISSN/ISBN: 0161-813X PMID: 8090361 Document Number: 424260
Document emailed within 1 workday
Related Documents
Slikker, W.; Paule, M.G. 1985: Developmental neuropharmacology/neurotoxicology Proceedings of the Western Pharmacology Society 28: 309-310Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Palmer, R.L. 1977: Rationale and usefulness of heparinization: an overview Texas Medicine 73(5): 68-72
Snodgrass, D.J. 1995: Chronic, developmental TMJ trauma and a new rationale for multiple phase treatment Functional Orthodontist 12(4): 4-9; 12
Rapaport, E. 1991: Overview: rationale of thrombolysis in treating acute myocardial infarction Heart and Lung: the Journal of Critical Care 20(5 Part 2): 538-541
Elster, A.B.; Marcell, A.V. 2003: Health care of adolescent males: overview, rationale, and recommendations Adolescent Medicine 14(3): 525
Salomon, D.R. 1997: Rationale and mechanisms of immunosuppression Kidney International. Suppl 58: S48-S50
Woo, K.T. 1989: IgA nephritis: a review of the pathogenetic mechanisms and the rationale for therapy Annals of the Academy of Medicine Singapore 18(6): 702-706
Mortensen, S.Aage. 2003: Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial Biofactors 18(1-4): 79-89
Abe-nagata, K.K. 1993: Demographic overview of the ageing situation in the ESCWA region and its developmental implications Population bulletin of ESCWA 1993(41-42): 153-175
Tropskaya, N.S.; Kislyakova, E.A.; Popova, T.S. 2016: Mechanisms of small Intestine Motor Disorders during Endotoxemia and Pathophysiological Rationale for the use of Tributyrine as Anti-Inflammatory and Prokinetic Pharmaconutrient Anesteziologiia i Reanimatologiia 61(1): 43-47
Yuasa, S. 1995: Developmental mechanisms of neural network in the cerebellar system Nihon Shinkei Seishin Yakurigaku Zasshi 15(2): 177-183
Yoshizawa, H. 1972: Developmental mechanisms in chronic rheumatoid arthritis--etiology and pathology Nursing Technique 18(11): 9-15
Kliushnik, T.P.; Lideman, R.R. 2001: Autoimmune mechanisms in the genesis of developmental abnormalities of the nervous system Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 7: 32-34
Michael, A.F. 1986: Immunologic mechanisms in renal disease--an overview Nihon Jinzo Gakkai Shi 28(7): 873-886
Takei, S.; Kaneko, H.; Kamio, S.; Uehara, A.; Hayata, Y. 1984: High altitude pulmonary edema in the Khumbu area of Nepal and its developmental mechanisms Nihon Kyobu Shikkan Gakkai Zasshi 22(12): 1109-1115
Arlien-Søborg, P. 1986: Bibliography. Neurotoxicology Neurotoxicology 7(4): 63-78
Oppenheim, R.W. 1997: Related mechanisms of action of growth factors and antioxidants in apoptosis: an overview Advances in Neurology 72: 69-78
Paganini, E.P. 1989: Overview of anemia associated with chronic renal disease: primary and secondary mechanisms Seminars in Nephrology 9(1 Suppl 1: 3-8
Lotti, M. 1996: Neurotoxicology: the Cinderella of neuroscience Neurotoxicology 17(2): 313-321